Thanks bear. So in my simple non-scientific mind in the early trials the ALT levels were elevated in 8% and seemed to be transient and in BoM the patient population is refined to CVD with DM and low HDL and the screening seemed to be more refined so perhaps less ALT elevation?

Plus, with 9 DSMBs ALT does not seem to be a problem?

Question marks because I want to understand if my thinking is on track. If so, it sounds like it may not be an issue for BoM.

GLTA...very exciting times.

Toinv